ALDH1A1-induced upregulation of SOD2 and GPX4, as well as ALDH1A1 itself, mitigates erlotinib-induced oxidative and carbonyl stress in cancer cells and imparts erlotinib resistance. The gene discussed is ALDH1A1; the disease is cancer.